## Inotropic Support in Pediatric Refractory Shock **Key Point:** Epinephrine is the drug of choice in pediatric shock that is refractory to fluid resuscitation, particularly when there is severe hypotension and signs of cardiogenic or mixed shock requiring both inotropic and vasopressor support. ### Clinical Context This child has: - Failed adequate fluid resuscitation (40 mL/kg bolus of normal saline) - Persistent severe hypotension (SBP 60 mmHg; critically low for a 2-year-old, where normal SBP ≈ 90 mmHg) - Signs of poor perfusion: capillary refill >3 seconds, weak pulses - Features of cardiogenic shock superimposed on hypovolemic shock ### Why Epinephrine is the Drug of Choice Here Epinephrine (adrenaline) is a mixed α- and β-adrenergic agonist: - **β₁-adrenergic effects:** ↑↑ Myocardial contractility, ↑ heart rate, ↑ cardiac output - **β₂-adrenergic effects:** Bronchodilation, mild vasodilation at low doses - **α-adrenergic effects:** Potent vasoconstriction → ↑ systemic vascular resistance → ↑ blood pressure **High-Yield:** In pediatric shock refractory to fluid resuscitation with severe hypotension, epinephrine is preferred because it simultaneously provides inotropic support (improves cardiac output) AND vasopressor support (raises systemic vascular resistance and blood pressure). This dual action is critical when the child is profoundly hypotensive. Per **PALS 2020 Guidelines** and **Nelson's Textbook of Pediatrics (21e)**, epinephrine is the first-line vasoactive agent for fluid-refractory shock with hemodynamic instability, including cardiogenic shock with hypotension in children. ### Dosing in Pediatric Shock - **Epinephrine infusion:** 0.1–1 μg/kg/min IV - Low doses (0.05–0.3 μg/kg/min): predominantly β-adrenergic (inotropic) - Higher doses (>0.3 μg/kg/min): α-adrenergic effects predominate (vasopressor) ### Comparison of Inotropic Agents in Pediatric Shock | Agent | Primary Effect | Afterload | BP Support | First-Line Use | Indication | |-------|----------------|-----------|------------|----------------|------------| | **Epinephrine** | ↑↑ Contractility + Vasoconstriction | ↑ | ↑↑ | **Yes** | Refractory shock; cardiogenic shock with hypotension | | **Dobutamine** | ↑↑ Contractility | ↓ (mild) | Minimal | No (2nd-line) | Cardiogenic shock with preserved BP; myocardial dysfunction without severe hypotension | | **Milrinone** | ↑ Contractility (PDE-3 inhibitor) | ↓↓ (marked) | ↓ | No | Diastolic dysfunction; post-operative low cardiac output | | **Levosimendan** | ↑ Contractility (inodilator) | ↓ | ↔ | No | Not standard in India/US pediatric practice | **Clinical Pearl:** Dobutamine, while an effective inotrope, causes mild vasodilation and does NOT reliably raise blood pressure. In a child with SBP of 60 mmHg and refractory shock, dobutamine alone is insufficient and may worsen hypotension. Epinephrine's combined inotropic and vasopressor properties make it the superior choice in this scenario. Milrinone is contraindicated in hypovolemic/refractory shock due to its pronounced vasodilatory effect. ### Why Other Options Are Incorrect - **Dobutamine (D):** Lacks adequate vasopressor activity; inappropriate as sole agent in severe hypotension with refractory shock - **Milrinone (B):** PDE-3 inhibitor; causes marked vasodilation and can worsen hypotension; reserved for post-operative low cardiac output states - **Levosimendan (A):** Calcium sensitizer/inodilator; not approved or routinely available in India; not standard pediatric practice [cite: PALS Guidelines 2020; Nelson's Textbook of Pediatrics 21e Ch. 78; Harrison's Principles of Internal Medicine 21e Ch. 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.